Pharmaceuticals

Global Personalized Genomics Market Expected To Reach $2.08 Billion By 2030 With 6.3% CAGR

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Personalized Genomics Market Between 2026 And 2030?

The personalized genomics market size has experienced rapid expansion in recent years. This market is expected to grow from $9.45 billion in 2025 to $10.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. Historically, the market’s expansion has been fueled by factors such as the decreasing costs of genetic sequencing, the increasing occurrence of chronic and genetic diseases, the rise in research-based genomics studies, the development of diagnostic laboratory infrastructure, and the early adoption of precision medicine approaches.

The personalized genomics market is anticipated to experience significant expansion over the coming years. By 2030, this market is projected to reach $19.61 billion, demonstrating a compound annual growth rate (CAGR) of 15.7%. Several factors contribute to this projected growth, including the integration of genomics into routine clinical practice, increasing demand for personalized medicine, progress in sequencing technologies, the expansion of wellness and ancestry testing, and greater investments from pharmaceutical and biotechnology companies. Key trends anticipated during the forecast period involve the rising adoption of direct-to-consumer genetic testing, the growing use of pharmacogenomics in treatment planning, an increasing need for preventive and predictive healthcare, the broadening of genetic testing in reproductive health, and heightened consumer awareness regarding lifestyle and wellness genomics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Major Factors Are Driving The Personalized Genomics Market Forward?

The increasing incidence of long-term illnesses is projected to stimulate the expansion of the personalized genomics market in the future. These enduring conditions necessitate continuous care and encompass ailments such as diabetes, cardiac disease, high blood pressure, and various intricate health challenges. The surge in chronic diseases is predominantly attributed to an aging demographic, inactive living habits, inadequate nutrition, and environmental elements, all of which foster the simultaneous emergence of numerous health problems. Personalized genomics aids in managing chronic illnesses by facilitating extensive genotyping and sequencing, which helps categorize patients based on their genetic risk, thereby enabling more accurate diagnoses, focused treatments, and improved preventative approaches. As an illustration, data from April 2025, provided by the U.S. Centers for Disease Control and Prevention (CDC), an organization based in the US, indicated that 76.4% of American adults, totaling approximately 194 million individuals, were living with at least one of 12 identified chronic conditions, whereas 51.4% (roughly 130 million) experienced two or more of these ailments. Consequently, the escalating occurrence of chronic illnesses is propelling the expansion of the personalized genomics market.

What Are The Different Segment Types In The Personalized Genomics Market Segment Breakdown?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Trends Are Shaping The Future Of The Personalized Genomics Market?

Leading companies within the personalized genomics market are concentrating on developing innovative technologies, particularly personalized genomics platforms, to deliver customized insights regarding health, wellness, and disease prevention. A personalized genomics platform functions as a system that processes an individual’s genetic data to offer bespoke insights and recommendations related to health, general well-being, and disease risk. For example, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service company, unveiled Geniee Decode Your DNA, a new customized genomics platform. This platform offers tailored insights into health, nutrition, and medication based on an individual’s genetic profile, thereby assisting in optimizing wellness, preventing illnesses, and personalizing treatments to achieve superior health outcomes.

Who Are The Well-Known Companies In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Get The Full Personalized Genomics Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Which Region Has The Greatest Market Share In The Personalized Genomics Market?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Personalized Genomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795